Niki BioSolutions, Inc. NIKI
1.50 USD -0.19 (-11.24%)
At closeNov 5, 2026, 4:00 PM EST
1.52 +0.02 +1.33%
After hours · Nov 5, 4:00 PM ET
1.42 Day range 1.64
1.42 52-week range 17.20
- YTD
- -85.85%
- 1 year
- -89.29%
- Market cap
- 4.68M
- EPS (ttm)
- -2.90
- YTD return
- -85.85%
- 1-year return
- -89.29%
- Volume
- 5.30K
- Avg volume
- 98.61K
- Open
- 1.64
- Previous close
- 1.69
- Day's range
- 1.42 – 1.64
- 52-week range
- 1.42 – 17.20
5m -0.31 (-17.13%)
Financials — quick view
NIKI Revenue — annual 0
NIKI Net income — annual -1.36M
NIKI EPS — annual -1.90
News
New York State Department Of Health Provides Clinical Laboratory Evaluation Program Test Approval To Niki BioSolutions' DiamiR Biosciences Subsidiary For Its APOE Genotyping Test 
Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine 
Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series 
Niki BioSolutions' DiamiR Biosciences Subsidiary To Perform Apolipoprotein E Genotyping On Plasma Samples From Global Alzheimer’s Platform Foundation Bio-Hermes-002 Trial Group 
Niki BioSolutions Partners with Global Alzheimer's Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002 
12 Health Care Stocks Moving In Tuesday's After-Market Session - 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Niki BioSolutions Enters At The Market Offering Agreement On October 9, 2026; May Sell Common Stock Up To $1.40M Aggregate Maximum Offering Price
Your note
Sign in to keep a note on NIKI — it syncs with the Stock Master app.